BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20537126)

  • 1. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo.
    Tran PL; Kim SA; Choi HS; Yoon JH; Ahn SG
    BMC Cancer; 2010 Jun; 10():276. PubMed ID: 20537126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25.
    Zan L; Chen Q; Zhang L; Li X
    Bioengineered; 2019 Dec; 10(1):374-382. PubMed ID: 31431131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor.
    Yin Z; Henry EC; Gasiewicz TA
    Biochemistry; 2009 Jan; 48(2):336-45. PubMed ID: 19113837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model.
    Moses MA; Henry EC; Ricke WA; Gasiewicz TA
    Cancer Prev Res (Phila); 2015 Mar; 8(3):249-57. PubMed ID: 25604133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin-3-Gallate Inhibits the Chaperone Activity of Plasmodium falciparum Hsp70 Chaperones and Abrogates Their Association with Functional Partners.
    Zininga T; Ramatsui L; Makhado PB; Makumire S; Achilinou I; Hoppe H; Dirr H; Shonhai A
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29206141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2.
    Li Y; Zhang T; Jiang Y; Lee HF; Schwartz SJ; Sun D
    Mol Pharm; 2009; 6(4):1152-9. PubMed ID: 19438225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
    Shankar S; Marsh L; Srivastava RK
    Mol Cell Biochem; 2013 Jan; 372(1-2):83-94. PubMed ID: 22971992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein.
    Palermo CM; Westlake CA; Gasiewicz TA
    Biochemistry; 2005 Apr; 44(13):5041-52. PubMed ID: 15794642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells.
    De Amicis F; Russo A; Avena P; Santoro M; Vivacqua A; Bonofiglio D; Mauro L; Aquila S; Tramontano D; Fuqua SA; Andò S
    Mol Nutr Food Res; 2013 May; 57(5):840-53. PubMed ID: 23322423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
    Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
    Ruckova E; Muller P; Nenutil R; Vojtesek B
    Cell Mol Biol Lett; 2012 Sep; 17(3):446-58. PubMed ID: 22669480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
    Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
    Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
    Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
    Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
    Kim J; Zhang X; Rieger-Christ KM; Summerhayes IC; Wazer DE; Paulson KE; Yee AS
    J Biol Chem; 2006 Apr; 281(16):10865-75. PubMed ID: 16495219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
    Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G
    J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
    Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
    J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.
    Donnelly A; Blagg BS
    Curr Med Chem; 2008; 15(26):2702-17. PubMed ID: 18991631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
    Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
    Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.